FindTrial
Sign In

A study on Immunity boosters for COVID-19

Knowledge, attitude, and practices relating to Immunity boosters for COVID-19 among health sciences and Non-Health Science professionals.

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2021/04/032613
Enrollment
500
Registered
2021-04-07
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

None listed

Sponsors

D Sreedhar
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Health science and Non-health science professionals

Exclusion criteria

Exclusion criteria: Pediatric and Geriatric Population

Design outcomes

Primary

MeasureTime frame
The outcomes to be measured include preference of health science and non-health science professionals in immunity booster before and after the outbreak of COVID-19, perceived level of protection after taking the immunity boosters, awareness about the mechanism, side effects and medically advised dose of the supplements and role of immunity boosters in treatment and prevention of COVID-19Timepoint: 4 WEEKS—

Secondary

MeasureTime frame
NilTimepoint: NA—

Countries

India

Contacts

Public ContactD Sreedhar

Manipal College of Pharmaceutical Sciences

d.sreedhar@manipal.edu

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026